Literature DB >> 11861215

The role of human papillomaviruses in human cancers.

Karl Münger1.   

Abstract

Of the more than 100 different human papillomavirus types (HPVs), the "high-risk" HPVs are associated with the vast majority of cervical carcinoma, and a pathologically distinct group of oropharyngeal tumors. In addition, other HPVs are associated with cutaneous tumors, in particular epidermodysplasia verruciformis and non-melanoma skin cancers. In general, HPV-associated cancers arise from a single accidental integration event of the viral genome into a host cell chromosome. Integration is a terminal event for the viral life cycle. Even though integration does not occur at specific chromosomal hot spots in the human genome, it follows a consistent pattern with respect to the viral genome, and expression of the HPV E6 and E7 genes is consistently retained. The normal function of E6 and E7 is to establish and maintain a cellular milieu that allows for viral genome replication. E6 and E7 target important cellular growth regulatory circuits among them the p53 and retinoblastoma tumor suppressors, respectively. Uncontrolled expression of the E6 and E7 proteins, as a consequence of viral integration is paramount to the establishment and maintenance of the tumorigenic state. In addition, expression of E6 and E7 increases genomic instability of the host cell thus accelerating malignant progression. Taken together, there is compelling molecular and epidemiological evidence in support of an oncogenic function of certain HPVs.

Entities:  

Mesh:

Year:  2002        PMID: 11861215     DOI: 10.2741/a800

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  34 in total

1.  Degradation of p53, not telomerase activation, by E6 is required for bypass of crisis and immortalization by human papillomavirus type 16 E6/E7.

Authors:  H R McMurray; D J McCance
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

2.  Targeting the human papillomavirus E6 and E7 oncogenes through expression of the bovine papillomavirus type 1 E2 protein stimulates cellular motility.

Authors:  Monique A Morrison; Richard J Morreale; Shailaja Akunuru; Matthew Kofron; Yi Zheng; Susanne I Wells
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

3.  Blocking Modification of Eukaryotic Initiation 5A2 Antagonizes Cervical Carcinoma via Inhibition of RhoA/ROCK Signal Transduction Pathway.

Authors:  Xiaojun Liu; Dong Chen; Jiamei Liu; Zhangtao Chu; Dongli Liu
Journal:  Technol Cancer Res Treat       Date:  2016-09-07

Review 4.  Tailoring to RB: tumour suppressor status and therapeutic response.

Authors:  Erik S Knudsen; Karen E Knudsen
Journal:  Nat Rev Cancer       Date:  2008-09       Impact factor: 60.716

5.  Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus.

Authors:  Koichi Watashi; Makoto Hijikata; Ayako Tagawa; Takahiro Doi; Hiroyuki Marusawa; Kunitada Shimotohno
Journal:  Mol Cell Biol       Date:  2003-11       Impact factor: 4.272

6.  Human papillomavirus E7 protein deregulates mitosis via an association with nuclear mitotic apparatus protein 1.

Authors:  Christine L Nguyen; Karl Münger
Journal:  J Virol       Date:  2008-12-03       Impact factor: 5.103

7.  Human papillomavirus infection and its possible correlation with p63 expression in cervical cancer in Japan, Mongolia, and Myanmar.

Authors:  Ulziibat Shirendeb; Yoshitaka Hishikawa; Shingo Moriyama; Ne Win; Minn Minn Myint Thu; Khin Swe Mar; Gerlee Khatanbaatar; Hideaki Masuzaki; Takehiko Koji
Journal:  Acta Histochem Cytochem       Date:  2009-12-22       Impact factor: 1.938

8.  Clonal selection for transcriptionally active viral oncogenes during progression to cancer.

Authors:  Brian A Van Tine; John C Kappes; N Sanjib Banerjee; Judith Knops; Lilin Lai; Renske D M Steenbergen; Chris L J M Meijer; Peter J F Snijders; Pamela Chatis; Thomas R Broker; Phillip T Moen; Louise T Chow
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

9.  Mullerian Inhibiting Substance inhibits cervical cancer cell growth via a pathway involving p130 and p107.

Authors:  Thanh U Barbie; David A Barbie; David T MacLaughlin; Shyamala Maheswaran; Patricia K Donahoe
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-11       Impact factor: 11.205

10.  Vaccination of rabbits with an adenovirus vector expressing the papillomavirus E2 protein leads to clearance of papillomas and infection.

Authors:  Janet L Brandsma; Mark Shlyankevich; Lixin Zhang; Martin D Slade; Edward C Goodwin; Woei Peh; Albert B Deisseroth
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.